StocksFundsScreenerSectorsWatchlists
USPH

USPH - US Physical Therapy Inc Stock Price, Fair Value and News

112.52USD+1.55 (+1.40%)Delayed as of 28 Mar 2024, 11:42 am ET

Market Summary

USPH
USD112.52+1.55
Delayedas of 28 Mar 2024, 11:42 am
1.40%

USPH Alerts

  • 5 major insider sales recently.
  • Big fall in earnings (Y/Y)

USPH Stock Price

View Fullscreen

USPH RSI Chart

USPH Valuation

Market Cap

1.7B

Price/Earnings (Trailing)

59.21

Price/Sales (Trailing)

2.76

EV/EBITDA

20.61

Price/Free Cashflow

20.4

USPH Price/Sales (Trailing)

USPH Profitability

EBT Margin

8.16%

Return on Equity

5.93%

Return on Assets

2.83%

Free Cashflow Yield

4.9%

USPH Fundamentals

USPH Revenue

Revenue (TTM)

604.8M

Rev. Growth (Yr)

9.65%

Rev. Growth (Qtr)

3.2%

USPH Earnings

Earnings (TTM)

28.2M

Earnings Growth (Yr)

-74.84%

Earnings Growth (Qtr)

-92.91%

Breaking Down USPH Revenue

52 Week Range

89.98124.11
(Low)(High)

Last 7 days

3.7%

Last 30 days

8.8%

Last 90 days

17.0%

Trailing 12 Months

12.8%

How does USPH drawdown profile look like?

USPH Financial Health

Current Ratio

2.28

USPH Investor Care

Dividend Yield

1.55%

Dividend/Share (TTM)

1.72

Shares Dilution (1Y)

15.65%

Diluted EPS (TTM)

1.29

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2023569.9M580.8M591.2M604.8M
2022514.4M528.1M541.8M553.1M
2021422.6M465.7M482.7M495.0M
2020478.5M435.9M427.6M423.0M
2019461.8M473.1M477.2M482.0M
2018424.8M435.7M445.8M453.9M
2017367.2M381.0M395.7M414.1M
2016341.0M348.1M352.4M356.5M
2015312.5M317.6M324.0M331.3M
2014271.1M282.4M294.3M305.1M
2013250.6M254.1M257.8M264.1M
2012242.0M245.5M247.9M249.7M
2011217.6M223.4M229.7M237.0M
20100204.7M208.0M211.2M
2009000201.4M

Tracking the Latest Insider Buys and Sells of US Physical Therapy Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Mar 13, 2024
trier clayton
sold
-42,800
107
-400
-
Mar 13, 2024
hendrickson carey p
sold
-193,103
107
-1,800
chief financial officer
Mar 13, 2024
binstein richard
sold
-213,100
106
-2,000
evp gen'l counsel & secretary
Mar 13, 2024
ham nancy
sold
-53,945
107
-500
-
Mar 04, 2024
kuntz edward l
sold
-260,650
104
-2,500
-
Mar 04, 2024
williams eric joseph
sold
-157,440
104
-1,500
co-chief operations officer
Mar 04, 2024
reeve graham d.
sold
-274,441
104
-2,629
coo
Feb 26, 2024
hendrickson carey p
acquired
-
-
8,100
chief financial officer
Feb 26, 2024
reeve graham d.
acquired
-
-
8,100
coo
Feb 26, 2024
binstein richard
acquired
-
-
8,100
evp gen'l counsel & secretary

1–10 of 50

Which funds bought or sold USPH recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Mar 22, 2024
PNC FINANCIAL SERVICES GROUP, INC.
reduced
-1.84
-1,094
333,628
-%
Mar 11, 2024
VANGUARD GROUP INC
added
2.53
3,903,550
98,954,400
-%
Mar 04, 2024
Northwest Bank & Trust Co
new
-
37,256
37,256
0.03%
Mar 01, 2024
GOLDMAN SACHS GROUP INC
added
90.22
1,940,480
4,023,680
-%
Feb 28, 2024
AMERICAN INTERNATIONAL GROUP, INC.
added
0.76
17,024
754,900
-%
Feb 26, 2024
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
unchanged
-
5,000
368,000
-%
Feb 16, 2024
PRICE T ROWE ASSOCIATES INC /MD/
reduced
-19.99
-448,000
1,939,000
-%
Feb 16, 2024
GSA CAPITAL PARTNERS LLP
new
-
350,000
350,000
0.03%
Feb 16, 2024
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO
unchanged
-
294
12,294
-%
Feb 15, 2024
State of Wyoming
added
12.06
10,483
86,527
0.02%

1–10 of 48

Are Funds Buying or Selling USPH?

Are funds buying USPH calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own USPH
No. of Funds

Unveiling US Physical Therapy Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
t. rowe price investment management, inc.
5.1%
761,260
SC 13G
Feb 13, 2024
morgan stanley
6.9%
1,039,417
SC 13G/A
Feb 13, 2024
vanguard group inc
7.09%
1,062,427
SC 13G/A
Feb 13, 2024
kayne anderson rudnick investment management llc
9.11%
1,365,766
SC 13G/A
Jan 22, 2024
blackrock inc.
15.5%
2,318,096
SC 13G/A
Feb 14, 2023
price t rowe associates inc /md/
0.2%
29,108
SC 13G/A
Feb 14, 2023
t. rowe price investment management, inc.
7.0%
915,831
SC 13G
Feb 14, 2023
kayne anderson rudnick investment management llc
11.78%
1,531,533
SC 13G/A
Feb 10, 2023
morgan stanley
5.1%
656,785
SC 13G
Feb 09, 2023
vanguard group inc
7.10%
922,576
SC 13G/A

Recent SEC filings of US Physical Therapy Inc

View All Filings
Date Filed Form Type Document
Mar 14, 2024
4
Insider Trading
Mar 14, 2024
4
Insider Trading
Mar 14, 2024
4
Insider Trading
Mar 14, 2024
4
Insider Trading
Mar 13, 2024
144
Notice of Insider Sale Intent
Mar 13, 2024
144
Notice of Insider Sale Intent
Mar 13, 2024
144
Notice of Insider Sale Intent
Mar 13, 2024
144
Notice of Insider Sale Intent
Mar 11, 2024
8-K
Current Report
Mar 11, 2024
8-K
Current Report

What is the Fair Value of USPH?

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Cheap
or
Expensive?


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks

Peers (Alternatives to US Physical Therapy Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
454.6B
371.6B
-6.04% 4.38%
20.31
1.22
14.64% 11.24%
106.2B
195.3B
3.13% 30.55%
19.78
0.54
8.17% -20.79%
100.0B
357.8B
1.79% 0.39%
11.97
0.28
10.95% 93.52%
87.7B
65.0B
6.93% 30.56%
16.74
1.35
7.86% -7.11%
41.9B
154.0B
-2.30% 15.93%
15.51
0.27
6.54% 124.79%
12.6B
14.3B
11.30% 47.77%
17.56
0.88
6.59% 6.24%
12.0B
12.1B
9.73% 82.98%
17.36
0.99
4.57% 23.40%
MID-CAP
9.7B
2.3B
11.19% 28.50%
35.74
4.3
6.06% 9.17%
7.2B
2.9B
-7.72% 12.77%
-333.68
2.47
12.20% -107.93%
2.3B
3.8B
3.63% -32.94%
11.05
0.61
-27.73% -52.50%
2.3B
1.4B
3.04% 7.42%
37.6
1.65
21.19% 34.42%
SMALL-CAP
1.7B
1.1B
9.76% -2.01%
26.93
1.59
11.31% 35.83%
1.2B
3.0B
4.38% 103.39%
-6.6
0.41
6.74% 20.73%
56.3M
-
28.14% -20.98%
-3.85
-
- -12.94%
16.9M
20.7M
-2.22% -14.90%
83.48
0.82
6.53% -85.60%

US Physical Therapy Inc News

Latest updates
Defense World22 Mar 202412:11 pm

US Physical Therapy Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue3.2%15515015114914114014113213012612711211710984.00113122117126116117
Gross Profit9.3%31.0028.0032.0031.0028.0027.0031.0027.0027.0030.0034.0026.0029.0030.0019.0016.0027.0027.0031.0027.0025.00
Costs and Expenses1.8%12412211911811311311010510396.0093.0086.0088.0079.0065.0097.0095.0090.0095.0090.0092.00
  S&GA Expenses15.4%14.0012.0012.0014.0012.0012.0011.0012.0011.0013.0012.0011.0011.0010.009.0012.0012.0011.0012.0011.0010.00
EBITDA Margin-9.6%0.12*0.13*0.13*0.13*0.14*0.16*0.16*0.17*0.17*0.19*0.20*0.21*---------
Interest Expenses-44.2%2.003.003.001.004.001.001.001.000.000.000.000.00-0.001.000.000.001.001.000.001.00
Income Taxes-60.7%1.004.004.003.001.003.004.003.004.004.005.003.005.004.004.000.002.003.005.003.003.00
Earnings Before Taxes-99.3%0.0016.0019.0014.005.0016.0019.0015.0018.0018.0022.0015.0023.0020.0019.004.0014.0016.0025.0015.0016.00
EBT Margin-10.3%0.08*0.09*0.09*0.10*0.10*0.13*0.14*0.14*0.15*0.16*0.17*0.18*---------
Net Income-92.9%1.009.0011.007.003.0010.0011.009.0010.0010.0012.008.0013.0011.0010.001.008.009.0015.008.0010.00
Net Income Margin-8.6%0.05*0.05*0.05*0.05*0.06*0.07*0.08*0.08*0.08*0.09*0.10*0.10*---------
Free Cashflow64.0%27.0016.0027.0011.0017.0014.0016.0012.0016.0025.0018.0018.00---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets-1.3%9971,0101,000868858800796764749630749749594575585594631561561523443
  Current Assets2.1%23322824211811111312296.0095.0079.0080.0076.0088.0083.0092.0014985.0093.0010781.0079.00
    Cash Equivalents3.5%15314816133.0032.0038.0049.0024.0029.0019.0020.0018.0033.0030.0044.0090.0024.0028.0035.0020.0023.00
  Net PPE0.1%26.0026.0025.0025.0025.0025.0024.0024.0023.0022.0022.0022.0022.0021.0023.0023.0022.0021.0020.0021.0020.00
  Goodwill-2.6%510523507501494450443444435374374360346337331331318317304293294
Liabilities0.9%34534234438437433333630429720119518218417019226018118819316592.00
  Current Liabilities24.1%10282.0086.0091.0085.0081.0085.0089.0083.0082.0075.0091.0093.0093.0087.0071.0061.0063.0057.0069.0042.00
    LT Debt, Current1.8%8.008.008.008.008.007.005.001.001.001.001.005.005.005.005.001.001.001.001.001.001.00
Shareholder's Equity-3.2%476492490319316319309302297291285277278266257242242237231221217
  Retained Earnings-6.2%224239238235233236232227224219216210212203195183184181177169167
  Additional Paid-In Capital0.7%28127927711211010910710510310299.0097.0096.0093.0091.0090.0087.0086.0084.0082.0080.00
Accumulated Depreciation0.2%85.0085.0084.0082.0080.0079.0077.0077.0075.0074.0072.0070.0069.0068.0067.0067.0066.0065.0064.0065.0064.00
Shares Outstanding-5.3%14.0015.0014.0013.0013.0013.0013.0013.0013.0013.0013.0013.00---------
Minority Interest-20.9%1.002.002.001.001.001.002.001.002.001.001.001.001.001.001.001.001.002.001.001.001.00
Float---1,100---774---838---565---779--
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations64.0%26,83516,36427,43011,34917,29913,72715,86211,64915,90524,94517,88217,67425,39326,24631,97616,38015,98417,84315,05813,56319,000
  Share Based Compensation-4.0%1,7851,8591,7861,8061,8021,8021,8141,8461,5872,8751,7541,6512,5921,9361,5031,8861,7231,7041,8301,7281,486
Cashflow From Investing50.3%-8,414-16,941-6,979-12,681-43,391-14,338-7,596-15,944-79,878-10,883-20,172-13,203-28,288-4,836-2,156-15,923-6,028-6,724-20,611-4,630-2,029
Cashflow From Financing-6.5%-13,281-12,476107,6822,34319,772-10,04716,077-43.0073,352-15,2934,772-19,4525,684-34,836-75,81665,546-14,264-18,12220,174-12,063-25,844
  Dividend Payments0%6,4456,445--5,3315,33110,659-4,8314,9069,028-----3,8323,832--2,918

USPH Income Statement

2023-12-31
CONSOLIDATED STATEMENTS OF NET INCOME - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenues:   
Net revenue$ 604,802$ 553,144$ 495,022
Operating cost:   
Salaries and related costs353,390319,191278,469
Rent, supplies, contract labor and other123,731116,38194,066
Provision for credit losses6,1725,5485,305
Total operating cost483,293441,120377,840
Gross profit121,509112,024117,182
Corporate office costs51,95346,11146,533
Impairment of goodwill and other intangible assets17,4959,1120
Operating income52,06156,80170,649
Other (expense) income   
Interest expense, debt and other(9,303)(5,779)(942)
Interest income from investments3,77400
Change in fair value of contingent earn-out consideration(1,550)2,5200
Change in revaluation of put-right liability2,582(5)0
Equity in earnings of unconsolidated affiliate9551,175112
Relief funds46704,597
Settlement of a legal matter00(2,635)
Resolution of a payor matter001,216
Other390859199
Total other (expense) income(2,685)(1,230)2,547
Income before taxes49,37655,57173,196
Provision for income taxes12,15612,16415,272
Net income37,22043,40757,924
Less: Net income attributable to non-controlling interest:   
Redeemable non-controlling interest - temporary equity(4,426)(6,902)(11,358)
Non-controlling interest - permanent equity(4,555)(4,347)(5,735)
Net income attributable to non-controlling interest(8,981)(11,249)(17,093)
Net income attributable to USPH shareholders$ 28,239$ 32,158$ 40,831
Basic earnings per share attributable to USPH shareholders (in dollars per share)$ 1.28$ 2.25$ 2.41
Diluted earnings per share attributable to USPH shareholders (in dollars per share)$ 1.28$ 2.25$ 2.41
Shares used in computation - basic (in shares)14,18812,98512,898
Shares used in computation - diluted (in shares)14,18812,98512,898
Dividends declared per common share (in dollars per share)$ 1.72$ 1.64$ 1.46
Net Patient Revenue [Member]   
Revenues:   
Net revenue$ 514,556$ 464,590$ 438,330
Other Revenue [Member]   
Revenues:   
Net revenue$ 90,246$ 88,554$ 56,692

USPH Balance Sheet

2023-12-31
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 152,825$ 31,594
Patient accounts receivable, less provision for credit losses of $2,736 and $2,829, respectively51,86651,934
Accounts receivable - other17,85416,671
Other current assets10,83011,067
Total current assets233,375111,266
Fixed assets:  
Furniture and equipment63,98262,074
Leasehold improvements46,94142,877
Fixed assets, gross110,923104,951
Less accumulated depreciation and amortization(84,821)(80,203)
Fixed assets, net26,10224,748
Operating lease right-of-use assets103,431103,004
Investment in unconsolidated affiliate12,25612,131
Goodwill509,571494,101
Other identifiable intangible assets, net109,682108,755
Other assets2,8214,149
Total assets997,238858,154
Current liabilities:  
Accounts payable - trade3,8983,300
Accounts payable - due to seller of acquired business03,204
Accrued expenses55,34437,413
Current portion of operating lease liabilities35,25233,709
Current portion of term loan and notes payable7,6917,863
Total current liabilities102,18585,489
Notes payable, net of current portion1,2891,913
Revolving facility031,000
Term loan, net of current portion and deferred financing costs137,702142,918
Deferred taxes24,81521,303
Operating lease liabilities, net of current portion76,65377,934
Other long-term liabilities2,35613,029
Total liabilities345,000373,586
Redeemable non-controlling interest - temporary equity174,828167,515
Commitments and Contingencies
U.S. Physical Therapy, Inc. ("USPH") shareholders' equity:  
Preferred stock, $.01 par value, 500,000 shares authorized, no shares issued and outstanding00
Common stock, $.01 par value, 20,000,000 shares authorized, 17,202,291 and 15,216,326 shares issued, respectively172152
Additional paid-in capital281,096110,317
Accumulated other comprehensive gain2,7824,004
Retained earnings223,772232,948
Treasury stock at cost, 2,214,737 shares(31,628)(31,628)
Total USPH shareholders' equity476,194315,793
Non-controlling interest - permanent equity1,2161,260
Total USPH shareholders' equity and non-controlling interest - permanent equity477,410317,053
Total liabilities, redeemable non-controlling interest, USPH shareholders' equity and non-controlling interest - permanent equity$ 997,238$ 858,154
USPH
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. The company was founded in 1990 and is based in Houston, Texas.
 CEO
 WEBSITEwww.usph.com
 EMPLOYEES3570

US Physical Therapy Inc Frequently Asked Questions


What is the ticker symbol for US Physical Therapy Inc? What does USPH stand for in stocks?

USPH is the stock ticker symbol of US Physical Therapy Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of US Physical Therapy Inc (USPH)?

As of Wed Mar 27 2024, market cap of US Physical Therapy Inc is 1.67 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of USPH stock?

You can check USPH's fair value in chart for subscribers.

What is the fair value of USPH stock?

You can check USPH's fair value in chart for subscribers. The fair value of US Physical Therapy Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of US Physical Therapy Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for USPH so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is US Physical Therapy Inc a good stock to buy?

The fair value guage provides a quick view whether USPH is over valued or under valued. Whether US Physical Therapy Inc is cheap or expensive depends on the assumptions which impact US Physical Therapy Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for USPH.

What is US Physical Therapy Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Mar 27 2024, USPH's PE ratio (Price to Earnings) is 59.21 and Price to Sales (PS) ratio is 2.76. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. USPH PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on US Physical Therapy Inc's stock?

In the past 10 years, US Physical Therapy Inc has provided 0.132 (multiply by 100 for percentage) rate of return.